4Mangunegoro H, Achmad Hudoyo.Efficacy of low--dose ofloxacin in the treatment of MDR-Tb in Indonesia.Chemotherapy 1999;45(Suppl 2):19-25.
5Maranetra KN. Quinolones and of Muhidrug-Resistant Tuberculosis.Chemotherapy, 1999;45:12-18.
6Yew WW, Kwan SY, Ma WK, et aL In-vitro activity of ofloxacin against Mycobactefium tuberculosis and its clinical efficacy in MDR-TB. J Antimierob Chemother, 1990,26:227-236.
7Saito H, Sato K,Tomioka H, et al.In Vitro antimycobacterial activity of a new quinolone levofloxacin (DR-3355).Tuber Lung Dis,1995;76:377-380.
8Grimado E.R.,Tupasi T.E.,Rivera A.B.,et al. Increaed resistanee to eiprofloxacin and ofloxacin in multidrug-resistant Myeobaceiu tuberculosis islates from patients seen at atertiary hospital in the Philippines. Int J Tuberc Lung Dis,2001;5(6):546-550.
9Yew WW, Chan CK, Chau CH,et al. Outcomes of patients with muhidrug-resistant pulmonary tuberculosis treated with ofloxaxcin/levofloxacin-containing regimens.Chest.2000; 117(3):774-751.
10Iseman,M.D.Management of Multidrug-Resistant.Tuber culosis.Chemotherapy, 1999;45:3-11.
